Ahead of the Desert Foot conference, SmartTRAK interviewed Dr. Michael Shore, Director of Medical Education and a founding member of PRESENT e-Learning Systems, to preview the conference which is being held Dec 4-7, 2019 in Phoenix, AZ

The multi-specialty conference provides comprehensive education for the overall management of the high-risk foot and lower extremities for podiatrists and other clinicians. Attendees will benefit from a wide variety of presentations, hands-on workshops and scientific research and will see cutting edge technology presented by the largest medical device and pharmaceutical companies in the industry.

To find our more about Desert Foot 2019, as well as PRESENT e-learning Systems, click on the following video to listen to SmartTRAK’s interview with Dr. Shore. (16:45 min)

Are you headed to Vegas for this year’s Orthopaedic Summit (OSET)? We sat down with Kristina Meyer, SmartTRAK’s Senior Analyst for Sports Medicine, for our new series, Know Before You Go, to get the scoop on what she’s looking forward to ahead of the meeting.

OSET will take place December 11-14th at the Bellagio in Las Vegas. The meeting touts itself as the “premier gathering of Total Joint (Knee, Hip, Shoulder), Foot & Ankle, Sports Medicine, Arthroscopic, Spine and Trauma Surgeons, Physician Assistants, Nurse Practitioners, Athletic Trainers, Physical and Occupational Therapists from across the globe.” Orthopaedic Summit 

SmartTRAK’s team is excited to attend and exhibit. Stop by the SmartTRAK booth, #128, to talk with Kristina and the SmartTRAK team about the latest news, trends and intelligence impacting the orthopedic industry.

1. Kristina, you are currently gearing up to attend OSET 2019. What are you looking forward to the most about the meeting?

Headed to Desert Foot? We have you covered.

SmartTRAK’s Senior Analyst for Advanced Wound Care, Terry Hayslett, is headed to Phoenix, Arizona for the 2019 Desert Foot Conference. We caught up with him ahead of the December 4-7th meeting as part of our new Know Before You Go series.

Desert Foot is one of the premier advanced wound care meetings. The meeting is held annually in Phoenix. “The conference brings together six groups involved with limb salvage preservation of the lower extremity from the Veterans Administration, VA Podiatric Residency Directors, Arizona Podiatric Medical Association, Association for the Advancement of Wound Care (AAWC), the Department of Defense, and healthcare professionals in the private sector, from across the country to a single conference to best meet their educational needs.” Desert Foot

1. Terry, you will soon be attending Desert Foot. What is it about this meeting that you are most excited about?

Julianne Burns, SmartTRAK's Senior Analyst, Spine, just returned from attending the 2019 Cervical Spine Research Society's (CSRS) 47th Annual Meeting in New York City.

Julianne discusses highlights from the meeting, including what’s on the horizon for the cervical spine market and the trend toward moving cervical spine procedures to an ASC setting in an interview with SmartTRAK Managing Editor Anne Staylor.

Click the video below to hear the interview, and scroll down to read the transcript.

New products help drive sequential improvement in growth 

The WW Market for Foot & Ankle Fixation exceeded $, up +3.9%, as reported, during Q319, up sequentially due to easy YoY comps. The US Foot & Ankle Fixation market also experienced a sequential increase, resulting in +4.3% reported growth. Major players reported improved growth while smaller players announced new product introductions throughout the quarter.

Stryker posted accelerated trauma & extremities growth in Q319,
reaching $, up +9.3% in the foot & ankle fixation segment according to SmartTRAK Financial Dashboard. The foot & ankle powerhouse reported US growth was positively impacted by double-digit growth across foot, ankle and shoulder products along with the T2 Alpha Nails. Stryker recouped lost share from Q2, gaining ~4.4% share to close Q3 at 25.6%. This gain allowed Stryker to take over the number one position from...

Among the many topics covered in the complete, comprehensive Q319 Extremities Market Recap* are:

Single-injection holding the torch in a market essentially flat, impacted by ferocious pricing pressures and declines in multi-injections

For the third quarter of 2019, the US Joint Fluid market revenue was essentially flat, +0.2% vs Q318. Aggregate growth for the quarter was pulled into slightly positive territory by a solid revenue growth of 14.3% YoY in single injection, according to the recently published SmartTRAK Financial Dashboard. However, strength in that segment was barely enough to counter revenue declines in 3- and 5-injections, while the 2-injection segment is still not large enough to make a significant contribution to the overall recovery of the US Joint Fluid market.

The single-injection segment held on to the market lead for Q319. Despite pricing pressure between competitors in this segment, revenue growth further solidifies the trend that the HA market is moving to the lowest treatment cycle.  For Q319, 3-injection products dropped down, strained by heavy competition and a persistent price war. Trailing behind is the 5-injections with...

Among the many topics covered in the comprehensive Q319 US Joint Fluid Market Recap* are:

AVA Scientific Meeting 2019 highlights key opportunities for improvement in vascular access from process bundles to emerging new products

Introduction

Acknowledgment of the importance of the vascular access nurse and team were obvious at this year’s Association for Vascular Access (AVA) Annual Scientific meeting. When Ramzy Nasrallah took over as CEO for the Association of Vascular Access (AVA) in 2017, he consolidated the mission of AVA “Protect the Patient, Educate the Clinician and Save the Line” to make it more memorable and to create a more powerful message. (See SmartTRAK interview with Nasrallah at AVA 2017). Nasrallah’s ultimate goal for AVA is to be “the biggest, most reputable, and highly regarded healthcare association in the world” with tens of thousands of members globally. Since taking the helm and advancing his agenda...

Rapid Medical CEO Ronen Eckhouse discusses the Company’s latest innovations, the plan for bringing its novel neurovascular devices to market, and Rapid’s strategy for competing in the market for neurovascular devices in an interview with SmartTRAK. 

To listen to the interview, click on the following video. A transcript of the interview is also provided below, as is a link to download the transcript.

SmartTRAK's Senior Regenerative Medicine Analyst, Freddy Buntoum, attended TOBI 2019 this summer. Here's a look at some of the key trends and takeaways in Orthobiologics from the 10th PRP & Regenerative Medicine Symposium, hosted by TOBI, that are still prevalent today.

Headed to AAHKS? Our VP of Content Development for Orthopedics, Lisa Mahan, weighs in on what's trending ahead of the meeting. 

A hot topic at #AAHKS2019 this year will be the move towards outpatient joint replacement surgery with CMS moving to reimburse hospital outpatient total hip replacement and reimbursement of total knee replacement in an ASC setting.

• Outpatient hip and knee replacement surgeries are expected to comprise 57% of all nonfracture knee and hip replacements by the year 2020. ACS Focus
• AAHKS currently does not believe CMS has taken adequate action to address issues arising from